category	term	number_of_genes	number_of_genes_in_background	ncbiTaxonId	inputGenes	preferredNames	p_value	fdr	description
COMPARTMENTS	GOCC:0005737	36	7871	9606	OAS3,BST2,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,SPATS2L	OAS3,BST2,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,SPATS2L	1.73e-07	0.0004	Cytoplasm
COMPARTMENTS	GOCC:0005622	42	11202	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,SPATS2L	4.27e-07	0.00049	Intracellular
COMPARTMENTS	GOCC:0043226	39	9848	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,C1R,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,C1R,SPATS2L	1.17e-06	0.0009	Organelle
COMPARTMENTS	GOCC:0042612	3	8	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	1.97e-06	0.0011	MHC class I protein complex
COMPARTMENTS	GOCC:0005829	20	2919	9606	OAS3,BST2,DTX3L,TREX1,MX2,WARS,STAT1,GBP1,IFIT1,ALDH4A1,ISG15,DDX58,SAMD9,PRKAR1A,LGALS9,MX1,OAS1,IFI35,PARP14,SPATS2L	OAS3,BST2,DTX3L,TREX1,MX2,WARS,STAT1,GBP1,IFIT1,ALDH4A1,ISG15,DDX58,SAMD9,PRKAR1A,LGALS9,MX1,OAS1,IFI35,PARP14,SPATS2L	3.31e-06	0.0014	Cytosol
COMPARTMENTS	GOCC:0043227	36	8685	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,IFI35,HLA-B,HLA-G,HELZ2,C1R,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,IFI35,HLA-B,HLA-G,HELZ2,C1R,SPATS2L	3e-06	0.0014	Membrane-bounded organelle
COMPARTMENTS	GOCC:0043229	37	9242	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,SPATS2L	3.99e-06	0.0014	Intracellular organelle
COMPARTMENTS	GOCC:0043231	33	7476	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,ISG15,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,IFI35,HLA-B,HLA-G,HELZ2,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,ISG15,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,IFI35,HLA-B,HLA-G,HELZ2,SPATS2L	4.23e-06	0.0014	Intracellular membrane-bounded organelle
COMPARTMENTS	GOCC:0110165	44	13853	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,SLC12A7,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,C1R,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,SLC12A7,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,C1R,SPATS2L	2.52e-05	0.0065	Cellular anatomical entity
COMPARTMENTS	GOCC:0071556	3	26	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	4.23e-05	0.0089	Integral component of lumenal side of endoplasmic reticulum membrane
COMPARTMENTS	GOCC:0031901	4	100	9606	HLA-E,IFITM3,HLA-B,HLA-G	HLA-E,IFITM3,HLA-B,HLA-G	0.0001	0.0169	Early endosome membrane
COMPARTMENTS	GOCC:0098844	2	5	9606	MX2,MX1	MX2,MX1	0.00011	0.0173	Postsynaptic endocytic zone membrane
COMPARTMENTS	GOCC:0045335	4	105	9606	CTSS,HLA-E,HLA-B,HLA-G	CTSS,HLA-E,HLA-B,HLA-G	0.00012	0.0178	Phagocytic vesicle
COMPARTMENTS	GOCC:0044327	2	7	9606	MX2,MX1	MX2,MX1	0.00019	0.0261	Dendritic spine head
COMPARTMENTS	GOCC:0012507	3	47	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00022	0.0281	ER to Golgi transport vesicle membrane
COMPARTMENTS	GOCC:0030670	3	48	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00023	0.0283	Phagocytic vesicle membrane
COMPARTMENTS	GOCC:0055038	3	54	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00032	0.0356	Recycling endosome membrane
COMPARTMENTS	GOCC:0005615	9	985	9606	BST2,CSF1,STAT1,CTSS,HLA-E,LGALS9,IFI35,HLA-B,C1R	BST2,CSF1,STAT1,CTSS,HLA-E,LGALS9,IFI35,HLA-B,C1R	0.00043	0.0452	Extracellular space
Process	GO:0060337	20	67	9606	OAS3,BST2,SAMHD1,TREX1,MX2,OAS2,SP100,STAT1,IFIT1,IFIT2,HLA-E,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,TREX1,MX2,OAS2,SP100,STAT1,IFIT1,IFIT2,HLA-E,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,HLA-B,HLA-G	4.24e-36	5.45e-32	Type i interferon signaling pathway
Process	GO:0045087	30	703	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	4.75e-32	1.52e-28	Innate immune response
Process	GO:0098542	31	900	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	1.49e-30	3.82e-27	Defense response to other organism
Process	GO:0009615	23	293	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFITM1,OAS1	1.53e-29	3.28e-26	Response to virus
Process	GO:0051607	21	210	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	6.61e-29	1.21e-25	Defense response to virus
Process	GO:0051707	32	1256	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	9.74e-28	1.56e-24	Response to other organism
Process	GO:0006955	33	1588	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	4.83e-26	5.64e-23	Immune response
Process	GO:0044419	33	1899	9606	OAS3,BST2,SP110,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SP110,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	1.34e-23	1.32e-20	Interspecies interaction between organisms
Process	GO:0019221	24	678	9606	OAS3,BST2,SAMHD1,TREX1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,TREX1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	5e-23	4.59e-20	Cytokine-mediated signaling pathway
Process	GO:0002252	25	969	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,STAT1,CTSS,GBP1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1,HLA-B,HLA-G,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,STAT1,CTSS,GBP1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1,HLA-B,HLA-G,C1R	7.82e-21	6.7e-18	Immune effector process
Process	GO:0071345	25	1013	9606	OAS3,BST2,SAMHD1,TREX1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,TREX1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	2.23e-20	1.79e-17	Cellular response to cytokine stimulus
Process	GO:0034341	15	182	9606	OAS3,BST2,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,LGALS9,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G	OAS3,BST2,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,LGALS9,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G	2.43e-19	1.56e-16	Response to interferon-gamma
Process	GO:0048525	13	105	9606	OAS3,BST2,OAS2,SP100,STAT1,IFIT1,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,OAS2,SP100,STAT1,IFIT1,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	5.91e-19	3.62e-16	Negative regulation of viral process
Process	GO:0060333	11	70	9606	OAS3,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,IFI30,OAS1,HLA-B,HLA-G	OAS3,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,IFI30,OAS1,HLA-B,HLA-G	3.5e-17	2.04e-14	Interferon-gamma-mediated signaling pathway
Process	GO:0050792	14	215	9606	OAS3,BST2,OAS2,SP100,STAT1,IFIT1,ISG15,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,OAS2,SP100,STAT1,IFIT1,ISG15,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFITM1,OAS1	1.01e-16	5.65e-14	Regulation of viral process
Process	GO:1903901	11	86	9606	OAS3,BST2,OAS2,IFIT1,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,OAS2,IFIT1,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	2.79e-16	1.44e-13	Negative regulation of viral life cycle
Process	GO:0045071	10	61	9606	OAS3,BST2,OAS2,IFIT1,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,OAS2,IFIT1,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1	7.34e-16	3.63e-13	Negative regulation of viral genome replication
Process	GO:0006950	33	3485	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	1.81e-15	8.63e-13	Response to stress
Process	GO:1903900	12	153	9606	OAS3,BST2,OAS2,IFIT1,ISG15,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,OAS2,IFIT1,ISG15,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFITM1,OAS1	2.55e-15	1.17e-12	Regulation of viral life cycle
Process	GO:0071346	12	161	9606	OAS3,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,LGALS9,IFI30,OAS1,HLA-B,HLA-G	OAS3,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,LGALS9,IFI30,OAS1,HLA-B,HLA-G	4.53e-15	2.01e-12	Cellular response to interferon-gamma
Process	GO:0071310	28	2369	9606	OAS3,BST2,SAMHD1,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	7.24e-15	3.1e-12	Cellular response to organic substance
Process	GO:0007166	25	2325	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	4.5e-12	1.7e-09	Cell surface receptor signaling pathway
Process	GO:0002682	21	1514	9606	BST2,SAMHD1,DTX3L,TREX1,CSF1,PARP9,STAT1,GBP1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,IFITM1,HLA-B,HLA-G,PARP14,C1R	BST2,SAMHD1,DTX3L,TREX1,CSF1,PARP9,STAT1,GBP1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,IFITM1,HLA-B,HLA-G,PARP14,C1R	5.26e-12	1.93e-09	Regulation of immune system process
Process	GO:0002831	13	406	9606	SAMHD1,DTX3L,TREX1,PARP9,STAT1,IFIT1,HLA-E,DDX58,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	SAMHD1,DTX3L,TREX1,PARP9,STAT1,IFIT1,HLA-E,DDX58,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	8.62e-12	3.08e-09	Regulation of response to biotic stimulus
Process	GO:0002697	13	418	9606	BST2,DTX3L,TREX1,PARP9,STAT1,IFIT1,HLA-E,DDX58,RSAD2,LGALS9,HLA-B,HLA-G,C1R	BST2,DTX3L,TREX1,PARP9,STAT1,IFIT1,HLA-E,DDX58,RSAD2,LGALS9,HLA-B,HLA-G,C1R	1.23e-11	4.26e-09	Regulation of immune effector process
Process	GO:0035455	6	23	9606	BST2,MX2,IFIT2,IFITM3,IFITM1,OAS1	BST2,MX2,IFIT2,IFITM3,IFITM1,OAS1	5.41e-11	1.83e-08	Response to interferon-alpha
Process	GO:0050776	16	896	9606	BST2,SAMHD1,TREX1,PARP9,STAT1,GBP1,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,IFITM1,HLA-B,HLA-G,PARP14,C1R	BST2,SAMHD1,TREX1,PARP9,STAT1,GBP1,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,IFITM1,HLA-B,HLA-G,PARP14,C1R	1.12e-10	3.69e-08	Regulation of immune response
Process	GO:0045824	7	61	9606	SAMHD1,TREX1,HLA-E,LGALS9,HLA-B,HLA-G,PARP14	SAMHD1,TREX1,HLA-E,LGALS9,HLA-B,HLA-G,PARP14	2.11e-10	6.78e-08	Negative regulation of innate immune response
Process	GO:0045088	10	301	9606	SAMHD1,TREX1,PARP9,STAT1,HLA-E,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	SAMHD1,TREX1,PARP9,STAT1,HLA-E,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	2.14e-09	6.71e-07	Regulation of innate immune response
Process	GO:0050777	8	154	9606	BST2,SAMHD1,TREX1,HLA-E,LGALS9,HLA-B,HLA-G,PARP14	BST2,SAMHD1,TREX1,HLA-E,LGALS9,HLA-B,HLA-G,PARP14	3.64e-09	1.11e-06	Negative regulation of immune response
Process	GO:0031347	13	674	9606	SAMHD1,DTX3L,TREX1,PARP9,STAT1,IFIT1,HLA-E,DDX58,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	SAMHD1,DTX3L,TREX1,PARP9,STAT1,IFIT1,HLA-E,DDX58,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	3.74e-09	1.12e-06	Regulation of defense response
Process	GO:0035456	5	31	9606	BST2,TREX1,STAT1,IFITM3,IFITM1	BST2,TREX1,STAT1,IFITM3,IFITM1	2.03e-08	5.66e-06	Response to interferon-beta
Process	GO:0007165	29	4876	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	5.43e-08	1.45e-05	Signal transduction
Process	GO:0032101	14	1013	9606	SAMHD1,DTX3L,TREX1,CSF1,PARP9,STAT1,IFIT1,HLA-E,DDX58,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	SAMHD1,DTX3L,TREX1,CSF1,PARP9,STAT1,IFIT1,HLA-E,DDX58,TRIM5,LGALS9,HLA-B,HLA-G,PARP14	5.31e-08	1.45e-05	Regulation of response to external stimulus
Process	GO:0023052	30	5239	9606	OAS3,BST2,SAMHD1,SLC12A7,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,SLC12A7,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	5.9e-08	1.55e-05	Signaling
Process	GO:0002683	10	450	9606	BST2,SAMHD1,TREX1,GBP1,HLA-E,PRKAR1A,LGALS9,HLA-B,HLA-G,PARP14	BST2,SAMHD1,TREX1,GBP1,HLA-E,PRKAR1A,LGALS9,HLA-B,HLA-G,PARP14	8.75e-08	2.2e-05	Negative regulation of immune system process
Process	GO:0007154	30	5320	9606	OAS3,BST2,SAMHD1,SLC12A7,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,SLC12A7,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	8.56e-08	2.2e-05	Cell communication
Process	GO:0048519	30	5389	9606	OAS3,BST2,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,OAS2,SP100,WARS,PARP9,STAT1,GBP1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,IFITM3,IFITM1,OAS1,HLA-B,HLA-G,HELZ2,PARP14	OAS3,BST2,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,OAS2,SP100,WARS,PARP9,STAT1,GBP1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,IFITM3,IFITM1,OAS1,HLA-B,HLA-G,HELZ2,PARP14	1.17e-07	2.89e-05	Negative regulation of biological process
Process	GO:0045953	4	16	9606	HLA-E,LGALS9,HLA-B,HLA-G	HLA-E,LGALS9,HLA-B,HLA-G	1.25e-07	3.03e-05	Negative regulation of natural killer cell mediated cytotoxicity
Process	GO:0016032	12	776	9606	SP110,SAMHD1,DTX3L,SP100,STAT1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,HLA-B	SP110,SAMHD1,DTX3L,SP100,STAT1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,HLA-B	1.8e-07	4.2e-05	Viral process
Process	GO:0002684	13	949	9606	TREX1,CSF1,PARP9,STAT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,HLA-B,HLA-G,C1R	TREX1,CSF1,PARP9,STAT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,HLA-B,HLA-G,C1R	1.97e-07	4.53e-05	Positive regulation of immune system process
Process	GO:0060759	7	175	9606	SAMHD1,TREX1,CSF1,PARP9,STAT1,DDX58,PARP14	SAMHD1,TREX1,CSF1,PARP9,STAT1,DDX58,PARP14	2.08e-07	4.69e-05	Regulation of response to cytokine stimulus
Process	GO:0002704	5	52	9606	BST2,HLA-E,LGALS9,HLA-B,HLA-G	BST2,HLA-E,LGALS9,HLA-B,HLA-G	2.17e-07	4.81e-05	Negative regulation of leukocyte mediated immunity
Process	GO:0002703	7	209	9606	BST2,HLA-E,DDX58,RSAD2,LGALS9,HLA-B,HLA-G	BST2,HLA-E,DDX58,RSAD2,LGALS9,HLA-B,HLA-G	6.63e-07	0.00014	Regulation of leukocyte mediated immunity
Process	GO:0001817	11	742	9606	BST2,TREX1,STAT1,GBP1,HLA-E,ISG15,DDX58,RSAD2,LGALS9,HLA-B,HLA-G	BST2,TREX1,STAT1,GBP1,HLA-E,ISG15,DDX58,RSAD2,LGALS9,HLA-B,HLA-G	9.7e-07	0.00019	Regulation of cytokine production
Process	GO:0042270	3	6	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	1e-06	0.0002	Protection from natural killer cell mediated cytotoxicity
Process	GO:0050778	10	607	9606	TREX1,PARP9,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,HLA-B,HLA-G,C1R	TREX1,PARP9,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,HLA-B,HLA-G,C1R	1.29e-06	0.00025	Positive regulation of immune response
Process	GO:0002230	4	32	9606	DTX3L,PARP9,STAT1,DDX58	DTX3L,PARP9,STAT1,DDX58	1.48e-06	0.00028	Positive regulation of defense response to virus by host
Process	GO:0050896	35	8046	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,PARP14,C1R	1.59e-06	0.0003	Response to stimulus
Process	GO:0050688	5	81	9606	DTX3L,PARP9,STAT1,IFIT1,DDX58	DTX3L,PARP9,STAT1,IFIT1,DDX58	1.72e-06	0.00032	Regulation of defense response to virus
Process	GO:0002700	6	152	9606	BST2,TREX1,HLA-E,DDX58,RSAD2,HLA-G	BST2,TREX1,HLA-E,DDX58,RSAD2,HLA-G	1.78e-06	0.00033	Regulation of production of molecular mediator of immune response
Process	GO:0002480	3	8	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	1.97e-06	0.00036	Antigen processing and presentation of exogenous peptide antigen via mhc class i, tap-independent
Process	GO:0046596	4	35	9606	TRIM5,LGALS9,IFITM3,IFITM1	TRIM5,LGALS9,IFITM3,IFITM1	2.05e-06	0.00037	Regulation of viral entry into host cell
Process	GO:0051716	31	6489	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	2.24e-06	0.00039	Cellular response to stimulus
Process	GO:0001959	6	163	9606	SAMHD1,TREX1,CSF1,PARP9,STAT1,PARP14	SAMHD1,TREX1,CSF1,PARP9,STAT1,PARP14	2.64e-06	0.00045	Regulation of cytokine-mediated signaling pathway
Process	GO:0002718	5	89	9606	BST2,HLA-E,DDX58,RSAD2,HLA-G	BST2,HLA-E,DDX58,RSAD2,HLA-G	2.67e-06	0.00045	Regulation of cytokine production involved in immune response
Process	GO:0060700	3	9	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	2.62e-06	0.00045	Regulation of ribonuclease activity
Process	GO:0002507	3	12	9606	HLA-E,LGALS9,HLA-G	HLA-E,LGALS9,HLA-G	5.39e-06	0.00084	Tolerance induction
Process	GO:2001198	3	12	9606	LGALS9,HLA-B,HLA-G	LGALS9,HLA-B,HLA-G	5.39e-06	0.00084	Regulation of dendritic cell differentiation
Process	GO:0019882	6	219	9606	TREX1,CTSS,HLA-E,IFI30,HLA-B,HLA-G	TREX1,CTSS,HLA-E,IFI30,HLA-B,HLA-G	1.36e-05	0.002	Antigen processing and presentation
Process	GO:0060760	4	58	9606	CSF1,PARP9,DDX58,PARP14	CSF1,PARP9,DDX58,PARP14	1.34e-05	0.002	Positive regulation of response to cytokine stimulus
Process	GO:0002720	4	59	9606	HLA-E,DDX58,RSAD2,HLA-G	HLA-E,DDX58,RSAD2,HLA-G	1.43e-05	0.0021	Positive regulation of cytokine production involved in immune response
Process	GO:0002699	6	223	9606	HLA-E,DDX58,RSAD2,LGALS9,HLA-B,HLA-G	HLA-E,DDX58,RSAD2,LGALS9,HLA-B,HLA-G	1.5e-05	0.0022	Positive regulation of immune effector process
Process	GO:0002483	3	18	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	1.56e-05	0.0023	Antigen processing and presentation of endogenous peptide antigen
Process	GO:0046597	3	18	9606	TRIM5,IFITM3,IFITM1	TRIM5,IFITM3,IFITM1	1.56e-05	0.0023	Negative regulation of viral entry into host cell
Process	GO:0002705	5	137	9606	HLA-E,DDX58,RSAD2,HLA-B,HLA-G	HLA-E,DDX58,RSAD2,HLA-B,HLA-G	2e-05	0.0028	Positive regulation of leukocyte mediated immunity
Process	GO:0070663	6	237	9606	BST2,CSF1,HLA-E,PRKAR1A,LGALS9,HLA-G	BST2,CSF1,HLA-E,PRKAR1A,LGALS9,HLA-G	2.1e-05	0.0029	Regulation of leukocyte proliferation
Process	GO:0002709	4	71	9606	HLA-E,RSAD2,HLA-B,HLA-G	HLA-E,RSAD2,HLA-B,HLA-G	2.85e-05	0.0038	Regulation of t cell mediated immunity
Process	GO:0002706	5	152	9606	HLA-E,RSAD2,LGALS9,HLA-B,HLA-G	HLA-E,RSAD2,LGALS9,HLA-B,HLA-G	3.24e-05	0.0043	Regulation of lymphocyte mediated immunity
Process	GO:0060334	3	26	9606	PARP9,STAT1,PARP14	PARP9,STAT1,PARP14	4.23e-05	0.0054	Regulation of interferon-gamma-mediated signaling pathway
Process	GO:0042590	4	80	9606	HLA-E,IFI30,HLA-B,HLA-G	HLA-E,IFI30,HLA-B,HLA-G	4.46e-05	0.0056	Antigen processing and presentation of exogenous peptide antigen via mhc class i
Process	GO:0048583	22	4114	9606	BST2,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,SP100,PARP9,STAT1,GBP1,IFIT1,HLA-E,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,IFITM1,HLA-B,HLA-G,PARP14,C1R	BST2,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,SP100,PARP9,STAT1,GBP1,IFIT1,HLA-E,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,IFITM1,HLA-B,HLA-G,PARP14,C1R	4.84e-05	0.006	Regulation of response to stimulus
Process	GO:0002519	2	3	9606	HLA-E,LGALS9	HLA-E,LGALS9	5.36e-05	0.0066	Natural killer cell tolerance induction
Process	GO:0002478	5	174	9606	CTSS,HLA-E,IFI30,HLA-B,HLA-G	CTSS,HLA-E,IFI30,HLA-B,HLA-G	6.06e-05	0.0074	Antigen processing and presentation of exogenous peptide antigen
Process	GO:0001914	3	33	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	8.17e-05	0.0097	Regulation of t cell mediated cytotoxicity
Process	GO:0002250	6	317	9606	TREX1,CTSS,HLA-E,HLA-B,HLA-G,C1R	TREX1,CTSS,HLA-E,HLA-B,HLA-G,C1R	0.0001	0.0119	Adaptive immune response
Process	GO:1903708	5	199	9606	CSF1,STAT1,ISG15,LGALS9,HLA-G	CSF1,STAT1,ISG15,LGALS9,HLA-G	0.00011	0.0129	Positive regulation of hemopoiesis
Process	GO:0002708	4	104	9606	HLA-E,RSAD2,HLA-B,HLA-G	HLA-E,RSAD2,HLA-B,HLA-G	0.00012	0.0135	Positive regulation of lymphocyte mediated immunity
Process	GO:0010468	23	4813	9606	BST2,SP110,DTX3L,TREX1,CSF1,SP100,WARS,PARP9,STAT1,GBP1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,ALKBH5,HLA-B,HLA-G,HELZ2,PARP14	BST2,SP110,DTX3L,TREX1,CSF1,SP100,WARS,PARP9,STAT1,GBP1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,ALKBH5,HLA-B,HLA-G,HELZ2,PARP14	0.00018	0.0198	Regulation of gene expression
Process	GO:0032944	5	220	9606	CSF1,HLA-E,PRKAR1A,LGALS9,HLA-G	CSF1,HLA-E,PRKAR1A,LGALS9,HLA-G	0.00018	0.0198	Regulation of mononuclear cell proliferation
Process	GO:0016185	2	7	9606	MX2,MX1	MX2,MX1	0.00019	0.0211	Synaptic vesicle budding from presynaptic endocytic zone membrane
Process	GO:0002711	3	47	9606	HLA-E,RSAD2,HLA-B	HLA-E,RSAD2,HLA-B	0.00022	0.0239	Positive regulation of t cell mediated immunity
Process	GO:0002729	2	8	9606	HLA-E,HLA-G	HLA-E,HLA-G	0.00024	0.0258	Positive regulation of natural killer cell cytokine production
Process	GO:0046719	2	8	9606	STAT1,IFIT1	STAT1,IFIT1	0.00024	0.0258	Regulation by virus of viral protein levels in host cell
Process	GO:0098884	2	8	9606	MX2,MX1	MX2,MX1	0.00024	0.0258	Postsynaptic neurotransmitter receptor internalization
Process	GO:0001961	3	50	9606	CSF1,PARP9,PARP14	CSF1,PARP9,PARP14	0.00026	0.0272	Positive regulation of cytokine-mediated signaling pathway
Process	GO:0032479	4	130	9606	TREX1,STAT1,ISG15,DDX58	TREX1,STAT1,ISG15,DDX58	0.00027	0.0282	Regulation of type i interferon production
Process	GO:0002476	2	9	9606	HLA-E,HLA-G	HLA-E,HLA-G	0.00029	0.03	Antigen processing and presentation of endogenous peptide antigen via mhc class ib
Process	GO:0032879	16	2740	9606	BST2,CTDSPL2,DTX3L,CSF1,MX2,OAS2,SP100,PARP9,CTSS,GBP1,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,IFITM1	BST2,CTDSPL2,DTX3L,CSF1,MX2,OAS2,SP100,PARP9,CTSS,GBP1,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,IFITM1	0.00033	0.0336	Regulation of localization
Process	GO:0002664	2	10	9606	HLA-B,HLA-G	HLA-B,HLA-G	0.00035	0.0351	Regulation of t cell tolerance induction
Process	GO:0002886	3	58	9606	HLA-E,DDX58,LGALS9	HLA-E,DDX58,LGALS9	0.0004	0.0388	Regulation of myeloid leukocyte mediated immunity
Process	GO:0070665	4	146	9606	BST2,CSF1,HLA-E,LGALS9	BST2,CSF1,HLA-E,LGALS9	0.00042	0.0407	Positive regulation of leukocyte proliferation
Process	GO:0050794	37	10932	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14	0.00044	0.0424	Regulation of cellular process
Process	GO:0001960	3	61	9606	SAMHD1,TREX1,PARP14	SAMHD1,TREX1,PARP14	0.00046	0.0436	Negative regulation of cytokine-mediated signaling pathway
Process	GO:0032655	3	61	9606	LGALS9,HLA-B,HLA-G	LGALS9,HLA-B,HLA-G	0.00046	0.0436	Regulation of interleukin-12 production
Process	GO:0002730	2	12	9606	BST2,DDX58	BST2,DDX58	0.00048	0.0451	Regulation of dendritic cell cytokine production
Process	GO:0032680	4	152	9606	TREX1,HLA-E,DDX58,LGALS9	TREX1,HLA-E,DDX58,LGALS9	0.00048	0.0451	Regulation of tumor necrosis factor production
Process	GO:0048584	14	2257	9606	BST2,DTX3L,TREX1,CSF1,PARP9,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,HLA-B,HLA-G,PARP14,C1R	BST2,DTX3L,TREX1,CSF1,PARP9,HLA-E,DDX58,TRIM5,RSAD2,LGALS9,HLA-B,HLA-G,PARP14,C1R	0.00049	0.0451	Positive regulation of response to stimulus
Process	GO:0050789	38	11475	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,C1R	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,C1R	0.00049	0.0451	Regulation of biological process
Process	GO:0001818	5	280	9606	BST2,GBP1,ISG15,DDX58,LGALS9	BST2,GBP1,ISG15,DDX58,LGALS9	0.00053	0.0477	Negative regulation of cytokine production
Process	GO:0035457	2	13	9606	IFIT2,OAS1	IFIT2,OAS1	0.00055	0.0495	Cellular response to interferon-alpha
Process	GO:0035563	2	13	9606	DTX3L,PARP9	DTX3L,PARP9	0.00055	0.0495	Positive regulation of chromatin binding
Process	GO:0042130	3	66	9606	PRKAR1A,LGALS9,HLA-G	PRKAR1A,LGALS9,HLA-G	0.00057	0.0495	Negative regulation of t cell proliferation
Process	GO:0046007	2	13	9606	PRKAR1A,LGALS9	PRKAR1A,LGALS9	0.00055	0.0495	Negative regulation of activated t cell proliferation
Component	GO:0042612	3	8	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	1.97e-06	0.0033	MHC class I protein complex
Component	GO:0005829	26	5193	9606	OAS3,BST2,DTX3L,TREX1,MX2,OAS2,WARS,PARP9,STAT1,GBP1,IFIT1,IFIT2,CMTR1,ISG15,DDX58,SAMD9,TRIM5,PRKAR1A,LGALS9,MX1,ALKBH5,IFI30,OAS1,IFI35,PARP14,SPATS2L	OAS3,BST2,DTX3L,TREX1,MX2,OAS2,WARS,PARP9,STAT1,GBP1,IFIT1,IFIT2,CMTR1,ISG15,DDX58,SAMD9,TRIM5,PRKAR1A,LGALS9,MX1,ALKBH5,IFI30,OAS1,IFI35,PARP14,SPATS2L	1.71e-05	0.0146	Cytosol
Component	GO:0071556	3	26	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	4.23e-05	0.018	Integral component of lumenal side of endoplasmic reticulum membrane
Component	GO:0043231	38	10761	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,SAMD9,TRIM5,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,SAMD9,TRIM5,RSAD2,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,SPATS2L	7.99e-05	0.0212	Intracellular membrane-bounded organelle
Component	GO:0005737	39	11428	9606	OAS3,BST2,DTX3L,TREX1,B4GAT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,SPATS2L	OAS3,BST2,DTX3L,TREX1,B3GNT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,IFIT2,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,TRIM5,RSAD2,PRKAR1A,LGALS9,MX1,ALKBH5,IFITM3,IFI30,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,SPATS2L	0.00012	0.0238	Cytoplasm
Component	GO:0098844	2	5	9606	MX2,MX1	MX2,MX1	0.00011	0.0238	Postsynaptic endocytic zone membrane
Function	GO:0001730	3	3	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	2.4e-07	0.00078	2-5-oligoadenylate synthetase activity
Function	GO:0003725	4	75	9606	OAS3,OAS2,DDX58,OAS1	OAS3,OAS2,DDX58,OAS1	3.5e-05	0.0397	Double-stranded rna binding
Function	GO:0042605	3	22	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	2.68e-05	0.0397	Peptide antigen binding
Function	GO:0042802	14	1896	9606	BST2,SAMHD1,TREX1,CSF1,SP100,WARS,STAT1,GBP1,ALDH4A1,DDX58,TRIM5,MX1,HLA-G,C1R	BST2,SAMHD1,TREX1,CSF1,SP100,WARS,STAT1,GBP1,ALDH4A1,DDX58,TRIM5,MX1,HLA-G,C1R	7.85e-05	0.0397	Identical protein binding
Function	GO:0042803	9	673	9606	BST2,TREX1,CSF1,SP100,WARS,STAT1,GBP1,TRIM5,HLA-G	BST2,TREX1,CSF1,SP100,WARS,STAT1,GBP1,TRIM5,HLA-G	2.45e-05	0.0397	Protein homodimerization activity
Function	GO:0044389	6	312	9606	DTX3L,PARP9,STAT1,ISG15,DDX58,PRKAR1A	DTX3L,PARP9,STAT1,ISG15,DDX58,PRKAR1A	9.4e-05	0.0397	Ubiquitin-like protein ligase binding
Function	GO:0097367	16	2226	9606	OAS3,SAMHD1,TREX1,MX2,OAS2,WARS,PARP9,CTSS,GBP1,IFI44L,DDX58,PRKAR1A,LGALS9,MX1,OAS1,HELZ2	OAS3,SAMHD1,TREX1,MX2,OAS2,WARS,PARP9,CTSS,GBP1,IFI44L,DDX58,PRKAR1A,LGALS9,MX1,OAS1,HELZ2	2.77e-05	0.0397	Carbohydrate derivative binding
TISSUES	BTO:0001424	12	1020	9606	CSF1,OAS2,STAT1,GBP1,IFI44L,PRKAR1A,MX1,IFITM3,IFITM1,OAS1,HLA-B,HLA-G	CSF1,OAS2,STAT1,GBP1,IFI44L,PRKAR1A,MX1,IFITM3,IFITM1,OAS1,HLA-B,HLA-G	3.12e-06	0.0047	Uterus
TISSUES	BTO:0003099	19	2593	9606	SAMHD1,CSF1,OAS2,SP100,WARS,STAT1,CTSS,GBP1,IFI44L,ALDH4A1,PRKAR1A,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14	SAMHD1,CSF1,OAS2,SP100,WARS,STAT1,CTSS,GBP1,IFI44L,ALDH4A1,PRKAR1A,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14	2.46e-06	0.0047	Internal female genital organ
TISSUES	BTO:0000081	28	6107	9606	SAMHD1,SLC12A7,CSF1,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44L,IFIT1,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,PRKAR1A,ZNFX1,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14,SPATS2L	SAMHD1,SLC12A7,CSF1,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44L,IFIT1,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,PRKAR1A,ZNFX1,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14,SPATS2L	3.27e-05	0.02	Reproductive system
TISSUES	BTO:0000083	27	5799	9606	SAMHD1,SLC12A7,CSF1,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44L,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,PRKAR1A,ZNFX1,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14,SPATS2L	SAMHD1,SLC12A7,CSF1,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44L,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,PRKAR1A,ZNFX1,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14,SPATS2L	4.06e-05	0.02	Female reproductive system
TISSUES	BTO:0000570	17	2543	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,SLC12A7,CSF1,OAS2,WARS,HLA-E,PRKAR1A,LGALS9,ALKBH5,OAS1,IFI35,HLA-B,HELZ2	OAS3,BST2,SP110,CTDSPL2,SAMHD1,SLC12A7,CSF1,OAS2,WARS,HLA-E,PRKAR1A,LGALS9,ALKBH5,OAS1,IFI35,HLA-B,HELZ2	3.58e-05	0.02	Hematopoietic system
TISSUES	BTO:0001489	42	12619	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,SLC12A7,DTX3L,B4GAT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,C1R,SPATS2L	OAS3,BST2,SP110,CTDSPL2,SAMHD1,SLC12A7,DTX3L,B3GNT1,CSF1,MX2,OAS2,SP100,WARS,PARP9,STAT1,CTSS,GBP1,IFI44,IFI44L,IFIT1,CMTR1,ALDH4A1,HLA-E,ISG15,DDX58,SAMD9,PRKAR1A,LGALS9,ZNFX1,MX1,ALKBH5,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,HELZ2,PARP14,C1R,SPATS2L	3.15e-05	0.02	Whole body
TISSUES	BTO:0000089	13	1675	9606	OAS3,BST2,SP110,CTDSPL2,SAMHD1,CSF1,OAS2,WARS,HLA-E,PRKAR1A,OAS1,IFI35,HLA-B	OAS3,BST2,SP110,CTDSPL2,SAMHD1,CSF1,OAS2,WARS,HLA-E,PRKAR1A,OAS1,IFI35,HLA-B	9.25e-05	0.0252	Blood
TISSUES	BTO:0000345	16	2645	9606	BST2,SAMHD1,SP100,STAT1,CTSS,ALDH4A1,HLA-E,ISG15,PRKAR1A,ALKBH5,IFITM3,IFI30,OAS1,HLA-B,PARP14,C1R	BST2,SAMHD1,SP100,STAT1,CTSS,ALDH4A1,HLA-E,ISG15,PRKAR1A,ALKBH5,IFITM3,IFI30,OAS1,HLA-B,PARP14,C1R	0.00022	0.0458	Digestive gland
TISSUES	BTO:0005810	12	1553	9606	SP110,SAMHD1,SLC12A7,CSF1,CTSS,HLA-E,PRKAR1A,LGALS9,ALKBH5,OAS1,HLA-B,HELZ2	SP110,SAMHD1,SLC12A7,CSF1,CTSS,HLA-E,PRKAR1A,LGALS9,ALKBH5,OAS1,HLA-B,HELZ2	0.00019	0.0458	Immune system
DISEASES	DOID:0060861	5	8	9606	OAS3,OAS2,DDX58,MX1,OAS1	OAS3,OAS2,DDX58,MX1,OAS1	7.2e-11	3.14e-07	Microphthalmia with limb anomalies
Keyword	KW-0051	20	127	9606	OAS3,BST2,SAMHD1,DTX3L,MX2,OAS2,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,SAMHD1,DTX3L,MX2,OAS2,PARP9,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	3.9e-31	2.64e-28	Antiviral defense
Keyword	KW-0391	26	522	9606	OAS3,BST2,SAMHD1,DTX3L,CSF1,MX2,OAS2,PARP9,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,CSF1,MX2,OAS2,PARP9,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,HLA-B,HLA-G,PARP14,C1R	7.43e-29	2.51e-26	Immunity
Keyword	KW-0399	22	324	9606	OAS3,BST2,SAMHD1,DTX3L,CSF1,MX2,OAS2,PARP9,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1,HLA-B,PARP14,C1R	OAS3,BST2,SAMHD1,DTX3L,CSF1,MX2,OAS2,PARP9,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1,HLA-B,PARP14,C1R	7.31e-27	1.65e-24	Innate immunity
Keyword	KW-0945	12	534	9606	SP110,SAMHD1,DTX3L,SP100,STAT1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,HLA-B	SP110,SAMHD1,DTX3L,SP100,STAT1,IFIT1,HLA-E,ISG15,DDX58,TRIM5,RSAD2,HLA-B	3.16e-09	5.34e-07	Host-virus interaction
Keyword	KW-0490	3	8	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	1.97e-06	0.00027	MHC I
Keyword	KW-0963	24	5028	9606	OAS3,BST2,DTX3L,TREX1,MX2,OAS2,SP100,WARS,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,SAMD9,TRIM5,LGALS9,MX1,OAS1,PARP14,SPATS2L	OAS3,BST2,DTX3L,TREX1,MX2,OAS2,SP100,WARS,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,SAMD9,TRIM5,LGALS9,MX1,OAS1,PARP14,SPATS2L	0.00011	0.0129	Cytoplasm
Keyword	KW-0948	2	7	9606	SAMHD1,TREX1	SAMHD1,TREX1	0.00019	0.0185	Aicardi-Goutieres syndrome
KEGG	hsa05160	9	156	9606	OAS3,MX2,OAS2,STAT1,IFIT1,DDX58,RSAD2,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,DDX58,RSAD2,MX1,OAS1	1.43e-10	4.81e-08	Hepatitis C
KEGG	hsa05169	9	193	9606	OAS3,OAS2,STAT1,HLA-E,ISG15,DDX58,OAS1,HLA-B,HLA-G	OAS3,OAS2,STAT1,HLA-E,ISG15,DDX58,OAS1,HLA-B,HLA-G	8.65e-10	1.45e-07	Epstein-Barr virus infection
KEGG	hsa05164	8	165	9606	OAS3,MX2,OAS2,STAT1,DDX58,RSAD2,MX1,OAS1	OAS3,MX2,OAS2,STAT1,DDX58,RSAD2,MX1,OAS1	6.11e-09	6.85e-07	Influenza A
KEGG	hsa05162	7	138	9606	OAS3,MX2,OAS2,STAT1,DDX58,MX1,OAS1	OAS3,MX2,OAS2,STAT1,DDX58,MX1,OAS1	4.39e-08	3.69e-06	Measles
KEGG	hsa05168	10	479	9606	OAS3,BST2,OAS2,SP100,STAT1,HLA-E,DDX58,OAS1,HLA-B,HLA-G	OAS3,BST2,OAS2,SP100,STAT1,HLA-E,DDX58,OAS1,HLA-B,HLA-G	1.54e-07	1.04e-05	Herpes simplex virus 1 infection
KEGG	hsa04612	5	63	9606	CTSS,HLA-E,IFI30,HLA-B,HLA-G	CTSS,HLA-E,IFI30,HLA-B,HLA-G	5.3e-07	2.97e-05	Antigen processing and presentation
KEGG	hsa05170	6	204	9606	BST2,SAMHD1,HLA-E,TRIM5,HLA-B,HLA-G	BST2,SAMHD1,HLA-E,TRIM5,HLA-B,HLA-G	9.2e-06	0.00044	Human immunodeficiency virus 1 infection
KEGG	hsa05165	7	325	9606	MX2,STAT1,HLA-E,ISG15,MX1,HLA-B,HLA-G	MX2,STAT1,HLA-E,ISG15,MX1,HLA-B,HLA-G	1.14e-05	0.00048	Human papillomavirus infection
KEGG	hsa04145	5	142	9606	CTSS,HLA-E,HLA-B,HLA-G,C1R	CTSS,HLA-E,HLA-B,HLA-G,C1R	2.36e-05	0.00088	Phagosome
KEGG	hsa04621	5	174	9606	OAS3,OAS2,STAT1,GBP1,OAS1	OAS3,OAS2,STAT1,GBP1,OAS1	6.06e-05	0.002	NOD-like receptor signaling pathway
KEGG	hsa05330	3	34	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	8.87e-05	0.0027	Allograft rejection
KEGG	hsa05332	3	36	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.0001	0.0029	Graft-versus-host disease
KEGG	hsa04940	3	39	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00013	0.0034	Type I diabetes mellitus
KEGG	hsa05320	3	48	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00023	0.0056	Autoimmune thyroid disease
KEGG	hsa05416	3	55	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00034	0.0076	Viral myocarditis
KEGG	hsa05203	4	182	9606	SP100,HLA-E,HLA-B,HLA-G	SP100,HLA-E,HLA-B,HLA-G	0.00094	0.0197	Viral carcinogenesis
KEGG	hsa05167	4	187	9606	STAT1,HLA-E,HLA-B,HLA-G	STAT1,HLA-E,HLA-B,HLA-G	0.001	0.0204	Kaposi sarcoma-associated herpesvirus infection
InterPro	IPR001039	3	9	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	2.62e-06	0.0028	MHC class I alpha chain, alpha1 alpha2 domains
InterPro	IPR002934	3	7	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	1.43e-06	0.0028	Polymerase, nucleotidyl transferase domain
InterPro	IPR006116	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.2e-07	0.0028	2-5OAS/ClassI-CCAase, nucleotidyltransferase domain
InterPro	IPR006117	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.2e-07	0.0028	2-5-oligoadenylate synthetase, C-terminal  conserved site
InterPro	IPR018952	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.2e-07	0.0028	2-5-oligoadenylate synthetase 1, domain 2/C-terminal
InterPro	IPR026774	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.2e-07	0.0028	2-5-oligoadenylate synthase
InterPro	IPR043518	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.2e-07	0.0028	2-5-oligoadenylate synthetase, N-terminal conserved site
InterPro	IPR011161	3	24	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	3.4e-05	0.0256	MHC class I-like antigen recognition-like
InterPro	IPR024644	2	2	9606	IFI44,IFI44L	IFI44,IFI44L	3.22e-05	0.0256	Interferon-induced protein 44 family
InterPro	IPR037055	3	24	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	3.4e-05	0.0256	MHC class I-like antigen recognition-like superfamily
InterPro	IPR043519	3	23	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	3.02e-05	0.0256	Nucleotidyltransferase superfamily
InterPro	IPR010579	2	4	9606	HLA-E,HLA-B	HLA-E,HLA-B	8.02e-05	0.0453	MHC class I, alpha chain, C-terminal
InterPro	IPR043563	2	4	9606	SP110,SP100	SP110,SP100	8.02e-05	0.0453	Nuclear body protein Sp110/Sp140/Sp140L
Pfam	PF10421	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.2e-07	0.0014	2-5-oligoadenylate synthetase 1, domain 2, C-terminus 
Pfam	PF01909	3	11	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.32e-06	0.0074	Nucleotidyltransferase domain
Pfam	PF00129	3	20	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	2.07e-05	0.0238	Class I Histocompatibility antigen, domains alpha 1 and 2
PMID	PMID:31665046	21	76	9606	OAS3,MX2,OAS2,SP100,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,SAMD9,TRIM5,RSAD2,LGALS9,ZNFX1,MX1,OAS1,IFI35,HELZ2	OAS3,MX2,OAS2,SP100,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,SAMD9,TRIM5,RSAD2,LGALS9,ZNFX1,MX1,OAS1,IFI35,HELZ2	2.35e-37	9.26e-31	(2019) Identifying novel biomarkers of the pediatric influenza infection by weighted co-expression network analysis.
PMID	PMID:34771433	18	38	9606	OAS3,BST2,SAMHD1,DTX3L,MX2,OAS2,PARP9,STAT1,CTSS,IFIT1,IFIT2,ISG15,DDX58,LGALS9,MX1,OAS1,HLA-B,PARP14	OAS3,BST2,SAMHD1,DTX3L,MX2,OAS2,PARP9,STAT1,CTSS,IFIT1,IFIT2,ISG15,DDX58,LGALS9,MX1,OAS1,HLA-B,PARP14	1.99e-35	3.93e-29	(2021) Multi-Omics Analysis of Glioblastoma Cells Sensitivity to Oncolytic Viruses.
PMID	PMID:33968942	17	64	9606	OAS3,BST2,SAMHD1,MX2,SP100,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,SAMD9,TRIM5,MX1,IFITM3,IFITM1	OAS3,BST2,SAMHD1,MX2,SP100,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,SAMD9,TRIM5,MX1,IFITM3,IFITM1	7.83e-30	1.03e-23	(2021) Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.
PMID	PMID:34372578	19	120	9606	OAS3,BST2,SAMHD1,MX2,OAS2,SP100,STAT1,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,ALKBH5,IFITM3,IFITM1,OAS1,HELZ2	OAS3,BST2,SAMHD1,MX2,OAS2,SP100,STAT1,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,ALKBH5,IFITM3,IFITM1,OAS1,HELZ2	1.42e-29	1.21e-23	(2021) Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
PMID	PMID:28701698	19	119	9606	OAS3,BST2,SAMHD1,CSF1,MX2,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,C1R	OAS3,BST2,SAMHD1,CSF1,MX2,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,C1R	1.23e-29	1.21e-23	(2017) Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin.
PMID	PMID:28805681	18	92	9606	OAS3,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFIT1,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM3,IFITM1,OAS1,HELZ2,PARP14	OAS3,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFIT1,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM3,IFITM1,OAS1,HELZ2,PARP14	1.74e-29	1.21e-23	(2017) Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
PMID	PMID:34490145	16	52	9606	OAS3,BST2,MX2,OAS2,SP100,STAT1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	OAS3,BST2,MX2,OAS2,SP100,STAT1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	5.94e-29	3.35e-23	(2021) Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling.
PMID	PMID:22703193	17	79	9606	BST2,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35	BST2,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35	1.86e-28	9.18e-23	(2012) Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjoegrens syndrome.
PMID	PMID:23847613	16	58	9606	BST2,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,DDX58,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35	BST2,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,DDX58,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35	2.7e-28	1.18e-22	(2013) The Interferon-Signature of Sjoegrens Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.
PMID	PMID:32325933	15	42	9606	BST2,MX2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	BST2,MX2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	5.71e-28	2.25e-22	(2020) RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle.
PMID	PMID:24528865	14	30	9606	BST2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,HLA-B	BST2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,HLA-B	1.85e-27	6.64e-22	(2014) Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
PMID	PMID:34857786	17	99	9606	BST2,SAMHD1,DTX3L,MX2,OAS2,SP100,PARP9,STAT1,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,IFITM3,IFITM1,HLA-B	BST2,SAMHD1,DTX3L,MX2,OAS2,SP100,PARP9,STAT1,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,IFITM3,IFITM1,HLA-B	5.94e-27	1.95e-21	(2021) Integrative epigenomics in Sjoegrens syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.
PMID	PMID:25128762	18	135	9606	OAS3,BST2,SAMHD1,OAS2,SP100,STAT1,IFI44L,IFIT1,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,C1R	OAS3,BST2,SAMHD1,OAS2,SP100,STAT1,IFI44L,IFIT1,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,C1R	9.57e-27	2.9e-21	(2014) Virus-host mucosal interactions during early SIV rectal transmission.
PMID	PMID:31937643	14	35	9606	OAS3,BST2,MX2,OAS2,STAT1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1,IFI35	OAS3,BST2,MX2,OAS2,STAT1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1,IFI35	1.08e-26	3.04e-21	(2020) Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.
PMID	PMID:34160465	14	36	9606	OAS3,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	OAS3,SAMHD1,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	1.5e-26	3.94e-21	(2021) Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis.
PMID	PMID:32164778	14	37	9606	OAS3,BST2,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	OAS3,BST2,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	2.06e-26	5.08e-21	(2020) Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
PMID	PMID:33922087	16	80	9606	OAS3,BST2,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,ISG15,DDX58,MX1,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,ISG15,DDX58,MX1,IFITM1,OAS1,IFI35,HLA-B,HLA-G	2.57e-26	5.97e-21	(2021) Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.
PMID	PMID:24380850	13	24	9606	OAS3,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,MX1,IFITM3,IFI30,OAS1,IFI35	OAS3,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,MX1,IFITM3,IFI30,OAS1,IFI35	3.44e-26	7.53e-21	(2014) Divergent gene expression responses to complicated grief and non-complicated grief.
PMID	PMID:32114504	13	25	9606	OAS3,BST2,OAS2,STAT1,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,OAS2,STAT1,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1	5.22e-26	1.08e-20	(2020) Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus.
PMID	PMID:22483866	15	61	9606	OAS3,BST2,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,IFITM1,OAS1	OAS3,BST2,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,IFITM1,OAS1	7.15e-26	1.41e-20	(2012) The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells.
PMID	PMID:24713352	14	42	9606	OAS3,BST2,SAMHD1,OAS2,SP100,STAT1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	OAS3,BST2,SAMHD1,OAS2,SP100,STAT1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	9.18e-26	1.73e-20	(2014) Interferon-stimulated genes: roles in viral pathogenesis.
PMID	PMID:34552595	15	65	9606	OAS3,BST2,MX2,OAS2,STAT1,GBP1,IFI44,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35,HLA-B	OAS3,BST2,MX2,OAS2,STAT1,GBP1,IFI44,IFIT2,ISG15,DDX58,MX1,IFITM3,OAS1,IFI35,HLA-B	1.66e-25	2.87e-20	(2021) Tissue-Resident-Memory CD8(+) T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.
PMID	PMID:22694362	14	44	9606	OAS3,SAMHD1,MX2,STAT1,GBP1,IFIT1,IFIT2,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM1,HLA-B	OAS3,SAMHD1,MX2,STAT1,GBP1,IFIT1,IFIT2,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM1,HLA-B	1.6e-25	2.87e-20	(2012) Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study.
PMID	PMID:33142113	15	72	9606	OAS3,BST2,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,BST2,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	6.51e-25	1.07e-19	(2020) Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
PMID	PMID:23369858	14	50	9606	OAS3,BST2,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,IFITM1,OAS1	OAS3,BST2,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,IFITM1,OAS1	7.48e-25	1.18e-19	(2013) What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?
PMID	PMID:23781071	14	51	9606	SAMHD1,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	SAMHD1,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	9.52e-25	1.44e-19	(2013) A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response.
PMID	PMID:30336493	13	36	9606	OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2.49e-24	3.63e-19	(2018) Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?
PMID	PMID:26695443	13	36	9606	BST2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,ISG15,SAMD9,ZNFX1,MX1,IFITM1,OAS1	BST2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,ISG15,SAMD9,ZNFX1,MX1,IFITM1,OAS1	2.49e-24	3.63e-19	(2016) Activation of IFNSTAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
PMID	PMID:29892288	14	56	9606	OAS3,BST2,DTX3L,OAS2,STAT1,GBP1,IFI44,IFIT1,IFIT2,ISG15,MX1,IFITM1,OAS1,IFI35	OAS3,BST2,DTX3L,OAS2,STAT1,GBP1,IFI44,IFIT1,IFIT2,ISG15,MX1,IFITM1,OAS1,IFI35	2.99e-24	4.07e-19	(2018) A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
PMID	PMID:34990653	15	82	9606	OAS3,BST2,OAS2,STAT1,CTSS,IFIT1,IFIT2,ISG15,DDX58,RSAD2,IFITM3,IFI30,IFITM1,OAS1,SPATS2L	OAS3,BST2,OAS2,STAT1,CTSS,IFIT1,IFIT2,ISG15,DDX58,RSAD2,IFITM3,IFI30,IFITM1,OAS1,SPATS2L	3.77e-24	4.9e-19	(2022) Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.
PMID	PMID:34997119	16	113	9606	OAS3,MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1,HLA-B,HLA-G	OAS3,MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1,HLA-B,HLA-G	3.94e-24	4.9e-19	(2022) Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.
PMID	PMID:27791205	14	57	9606	BST2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,SAMD9,ZNFX1,MX1,IFITM1,OAS1,PARP14	BST2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,SAMD9,ZNFX1,MX1,IFITM1,OAS1,PARP14	3.72e-24	4.9e-19	(2016) Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.
PMID	PMID:34880855	12	24	9606	OAS3,BST2,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,BST2,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	6.96e-24	8.32e-19	(2021) Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
PMID	PMID:34367124	13	41	9606	MX2,OAS2,GBP1,IFI44,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1	MX2,OAS2,GBP1,IFI44,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1	1.04e-23	1.21e-18	(2021) Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.
PMID	PMID:34467632	13	41	9606	BST2,SAMHD1,CSF1,MX2,STAT1,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,OAS1,HLA-B	BST2,SAMHD1,CSF1,MX2,STAT1,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,OAS1,HLA-B	1.04e-23	1.21e-18	(2021) Inhibition of IRGM establishes a robust antiviral immune state to restrict pathogenic viruses.
PMID	PMID:31641281	13	42	9606	OAS3,SAMHD1,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1,SPATS2L	OAS3,SAMHD1,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1,SPATS2L	1.36e-23	1.49e-18	(2020) A clinical score to guide in decision making for monogenic type I IFNopathies.
PMID	PMID:30915053	13	42	9606	BST2,SAMHD1,MX2,SP100,STAT1,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM1,OAS1	BST2,SAMHD1,MX2,SP100,STAT1,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM1,OAS1	1.36e-23	1.49e-18	(2019) Comparative Description of the Expression Profile of Interferon-Stimulated Genes in Multiple Cell Lineages Targeted by HIV-1 Infection.
PMID	PMID:17488182	14	64	9606	OAS3,MX2,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,RSAD2,MX1,OAS1	OAS3,MX2,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,RSAD2,MX1,OAS1	1.57e-23	1.63e-18	(2007) Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
PMID	PMID:30621583	15	92	9606	CSF1,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,IFI35	CSF1,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,IFI35	1.81e-23	1.79e-18	(2019) Bacterial and viral pathogen-associated molecular patterns induce divergent early transcriptomic landscapes in a bovine macrophage cell line.
PMID	PMID:29176033	13	43	9606	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,ISG15,DDX58,MX1,IFI30,IFITM1,OAS1,IFI35	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,ISG15,DDX58,MX1,IFI30,IFITM1,OAS1,IFI35	1.77e-23	1.79e-18	(2017) TNFalpha-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion.
PMID	PMID:27479908	15	92	9606	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,RSAD2,MX1,IFITM1,OAS1,IFI35,HLA-B	OAS3,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT2,HLA-E,ISG15,RSAD2,MX1,IFITM1,OAS1,IFI35,HLA-B	1.81e-23	1.79e-18	(2016) Tensor decomposition for multiple-tissue gene expression experiments.
PMID	PMID:26008703	13	43	9606	BST2,MX2,OAS2,STAT1,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	BST2,MX2,OAS2,STAT1,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.77e-23	1.79e-18	(2015) Insights into Human Astrocyte Response to H5N1 Infection by Microarray Analysis.
PMID	PMID:22328912	13	44	9606	BST2,STAT1,GBP1,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	BST2,STAT1,GBP1,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	2.29e-23	2.1e-18	(2011) Interferon-stimulated genes and their antiviral effector functions.
PMID	PMID:33560295	14	68	9606	OAS3,BST2,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,RSAD2,MX1,OAS1,IFI35,SPATS2L	OAS3,BST2,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,RSAD2,MX1,OAS1,IFI35,SPATS2L	3.34e-23	3e-18	(2021) An OMICs based meta-analysis to support infection state stratification.
PMID	PMID:33253099	11	16	9606	OAS3,BST2,MX2,OAS2,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,OAS1	OAS3,BST2,MX2,OAS2,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,OAS1	4.11e-23	3.6e-18	(2021) Increased expression of interferon regulated and antiviral response genes in CD31+CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease.
PMID	PMID:27344170	12	29	9606	OAS3,BST2,CTSS,IFI44,IFIT1,ISG15,DDX58,LGALS9,MX1,IFITM3,IFITM1,IFI35	OAS3,BST2,CTSS,IFI44,IFIT1,ISG15,DDX58,LGALS9,MX1,IFITM3,IFITM1,IFI35	4.35e-23	3.73e-18	(2016) Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.
PMID	PMID:30581389	13	47	9606	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1	MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1	4.81e-23	4.04e-18	(2018) Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.
PMID	PMID:28806913	12	31	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1	8.43e-23	6.93e-18	(2017) Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.
PMID	PMID:34904133	13	51	9606	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1,SPATS2L	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1,SPATS2L	1.22e-22	9.78e-18	(2022) Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults.
PMID	PMID:32508817	13	51	9606	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	1.22e-22	9.78e-18	(2020) Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection.
PMID	PMID:34818375	11	19	9606	OAS3,MX2,OAS2,STAT1,IFI44L,ISG15,DDX58,RSAD2,MX1,OAS1,IFI35	OAS3,MX2,OAS2,STAT1,IFI44L,ISG15,DDX58,RSAD2,MX1,OAS1,IFI35	1.71e-22	1.32e-17	(2021) Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis.
PMID	PMID:29215570	13	53	9606	OAS3,BST2,MX2,OAS2,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,BST2,MX2,OAS2,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.89e-22	1.43e-17	(2017) Host Cell Restriction Factors that Limit Influenza A Infection.
PMID	PMID:24678238	13	53	9606	OAS3,BST2,OAS2,GBP1,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1,IFI35	OAS3,BST2,OAS2,GBP1,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1,IFI35	1.89e-22	1.43e-17	(2012) High-Dimensional Longitudinal Genomic Data: An analysis used for monitoring viral infections.
PMID	PMID:35281454	12	34	9606	DTX3L,MX2,PARP9,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	DTX3L,MX2,PARP9,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	2.13e-22	1.55e-17	(2022) Streptococcus pneumoniae and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells.
PMID	PMID:35075430	12	35	9606	OAS3,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,OAS1	OAS3,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,OAS1	2.85e-22	2.05e-17	(2022) Bioinformatic Analysis Identifies Biomarkers and Treatment Targets in Primary Sjoegrens Syndrome Patients with Fatigue.
PMID	PMID:31465999	13	57	9606	OAS3,BST2,SAMHD1,MX2,STAT1,IFI44,IFIT1,ISG15,DDX58,SAMD9,RSAD2,MX1,OAS1	OAS3,BST2,SAMHD1,MX2,STAT1,IFI44,IFIT1,ISG15,DDX58,SAMD9,RSAD2,MX1,OAS1	4.35e-22	3.06e-17	(2019) Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii.
PMID	PMID:35086375	12	37	9606	OAS3,BST2,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,ISG15,MX1,OAS1,IFI35	OAS3,BST2,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,ISG15,MX1,OAS1,IFI35	5.02e-22	3.48e-17	(2022) Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis.
PMID	PMID:34180358	11	22	9606	OAS3,OAS2,STAT1,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,OAS2,STAT1,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,OAS1	6.04e-22	4.11e-17	(2021) Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis.
PMID	PMID:33450175	13	59	9606	OAS3,BST2,SAMHD1,MX2,STAT1,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3	OAS3,BST2,SAMHD1,MX2,STAT1,IFIT1,IFIT2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3	6.48e-22	4.33e-17	(2021) Evolutionary conflicts and adverse effects of antiviral factors.
PMID	PMID:30804934	12	38	9606	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1	OAS3,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1	6.6e-22	4.34e-17	(2019) The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
PMID	PMID:25902143	12	39	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44,IFIT1,IFIT2,ISG15,TRIM5,RSAD2,MX1	OAS3,SAMHD1,MX2,OAS2,STAT1,IFI44,IFIT1,IFIT2,ISG15,TRIM5,RSAD2,MX1	8.61e-22	5.57e-17	(2015) Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
PMID	PMID:33290632	12	40	9606	OAS3,OAS2,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OAS2,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.12e-21	7.11e-17	(2021) G-quadruplex-forming nucleic acids interact with splicing factor 3B subunit 2 and suppress innate immune gene expression.
PMID	PMID:19646728	13	63	9606	MX2,OAS2,STAT1,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1	MX2,OAS2,STAT1,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFITM1,OAS1	1.39e-21	8.68e-17	(2009) TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS.
PMID	PMID:29880853	13	64	9606	MX2,PARP9,STAT1,IFI44L,IFIT1,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1,IFI35,PARP14	MX2,PARP9,STAT1,IFI44L,IFIT1,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1,IFI35,PARP14	1.67e-21	1.03e-16	(2018) Immunoprofiles of human Sertoli cells infected with Zika virus reveals unique insights into host-pathogen crosstalk.
PMID	PMID:34559160	12	42	9606	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	1.85e-21	1.12e-16	(2021) CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction.
PMID	PMID:31949544	11	25	9606	BST2,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,MX1,IFITM3,OAS1	BST2,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,MX1,IFITM3,OAS1	1.87e-21	1.12e-16	(2019) Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
PMID	PMID:29947965	11	25	9606	OAS3,BST2,OAS2,IFI44,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM1,IFI35	OAS3,BST2,OAS2,IFI44,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM1,IFI35	1.87e-21	1.12e-16	(2018) Of mice and men: the host response to influenza virus infection.
PMID	PMID:35024587	13	66	9606	DTX3L,CSF1,OAS2,PARP9,CTSS,IFI44,IFIT1,IFIT2,ISG15,DDX58,MX1,PARP14,C1R	DTX3L,CSF1,OAS2,PARP9,CTSS,IFI44,IFIT1,IFIT2,ISG15,DDX58,MX1,PARP14,C1R	2.38e-21	1.38e-16	(2022) Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells.
PMID	PMID:31364746	11	26	9606	OAS3,BST2,MX2,OAS2,IFI44,IFIT1,ISG15,DDX58,SAMD9,RSAD2,OAS1	OAS3,BST2,MX2,OAS2,IFI44,IFIT1,ISG15,DDX58,SAMD9,RSAD2,OAS1	2.65e-21	1.52e-16	(2019) Characteristic genes in THP-1 derived macrophages infected with Mycobacterium tuberculosis H37Rv strain identified by integrating bioinformatics methods.
PMID	PMID:35139383	12	44	9606	OAS3,BST2,OAS2,PARP9,STAT1,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,BST2,OAS2,PARP9,STAT1,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	3.01e-21	1.69e-16	(2022) Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine.
PMID	PMID:24265599	12	44	9606	OAS2,SP100,STAT1,GBP1,IFI44,IFI44L,IFIT1,RSAD2,MX1,IFITM1,OAS1,IFI35	OAS2,SP100,STAT1,GBP1,IFI44,IFI44L,IFIT1,RSAD2,MX1,IFITM1,OAS1,IFI35	3.01e-21	1.69e-16	(2013) Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.
PMID	PMID:25703554	12	45	9606	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT2,ISG15,IFITM3,IFITM1,OAS1,IFI35	OAS3,OAS2,STAT1,GBP1,IFI44,IFI44L,IFIT2,ISG15,IFITM3,IFITM1,OAS1,IFI35	3.8e-21	2.08e-16	(2015) The human immune response to tuberculosis and its treatment: a view from the blood.
PMID	PMID:25170834	12	45	9606	OAS3,CSF1,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1	OAS3,CSF1,MX2,OAS2,STAT1,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1	3.8e-21	2.08e-16	(2014) HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.
PMID	PMID:35262626	14	99	9606	OAS3,SAMHD1,OAS2,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1,SPATS2L	OAS3,SAMHD1,OAS2,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1,SPATS2L	3.98e-21	2.12e-16	(2022) DNA damage contributes to neurotoxic inflammation in Aicardi-Goutieres syndrome astrocytes.
PMID	PMID:23071754	14	100	9606	BST2,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,SAMD9,LGALS9,MX1,IFITM1	BST2,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,SAMD9,LGALS9,MX1,IFITM1	4.53e-21	2.38e-16	(2012) TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.
PMID	PMID:32276512	11	28	9606	OAS3,OAS2,STAT1,IFI44L,IFIT2,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1	OAS3,OAS2,STAT1,IFI44L,IFIT2,ISG15,DDX58,MX1,IFITM3,IFITM1,OAS1	5.18e-21	2.67e-16	(2020) 2, 5-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Iota IFN Signaling Pathway.
PMID	PMID:20709292	14	101	9606	OAS3,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFIT1,IFIT2,ISG15,RSAD2,LGALS9,MX1,PARP14	OAS3,MX2,OAS2,PARP9,STAT1,GBP1,IFI44,IFIT1,IFIT2,ISG15,RSAD2,LGALS9,MX1,PARP14	5.15e-21	2.67e-16	(2010) Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
PMID	PMID:28432378	12	47	9606	OAS3,BST2,MX2,OAS2,STAT1,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	OAS3,BST2,MX2,OAS2,STAT1,ISG15,TRIM5,RSAD2,MX1,IFITM3,IFITM1,OAS1	6e-21	3.03e-16	(2017) Advances in anti-viral immune defence: revealing the importance of the IFN JAKSTAT pathway.
PMID	PMID:24065129	11	29	9606	OAS3,BST2,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,MX1,IFITM1,OAS1	OAS3,BST2,MX2,OAS2,STAT1,IFIT1,IFIT2,ISG15,MX1,IFITM1,OAS1	7.13e-21	3.56e-16	(2013) IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
PMID	PMID:33276587	12	48	9606	BST2,MX2,OAS2,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	BST2,MX2,OAS2,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	7.48e-21	3.69e-16	(2020) Host Cell Restriction Factors of Paramyxoviruses and Pneumoviruses.
PMID	PMID:34599159	14	105	9606	CTDSPL2,DTX3L,OAS2,PARP9,IFI44L,IFIT1,IFIT2,CMTR1,DDX58,SAMD9,OAS1,IFI35,HLA-B,PARP14	CTDSPL2,DTX3L,OAS2,PARP9,IFI44L,IFIT1,IFIT2,CMTR1,DDX58,SAMD9,OAS1,IFI35,HLA-B,PARP14	8.5e-21	4.14e-16	(2021) Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line.
PMID	PMID:33362771	14	106	9606	OAS3,BST2,OAS2,STAT1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	OAS3,BST2,OAS2,STAT1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35	9.6e-21	4.62e-16	(....) a network-based analysis reveals the mechanism underlying vitamin d in suppressing cytokine storm and virus in sars-cov-2 infection.
PMID	PMID:28106799	11	32	9606	OAS3,SAMHD1,MX2,OAS2,STAT1,CTSS,IFIT1,ISG15,DDX58,MX1,OAS1	OAS3,SAMHD1,MX2,OAS2,STAT1,CTSS,IFIT1,ISG15,DDX58,MX1,OAS1	1.77e-20	8.39e-16	(2017) RNA Editing, ADAR1, and the Innate Immune Response.
PMID	PMID:35326463	12	53	9606	MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	MX2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	2.14e-20	1e-15	(2022) Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription.
PMID	PMID:35047003	12	53	9606	OAS3,BST2,MX2,OAS2,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,BST2,MX2,OAS2,IFI44,IFI44L,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1	2.14e-20	1e-15	(2021) Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis.
PMID	PMID:32252809	11	33	9606	OAS3,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	2.35e-20	1.08e-15	(2020) Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
PMID	PMID:31058188	11	33	9606	OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,RSAD2,IFI35,PARP14	OAS2,PARP9,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,RSAD2,IFI35,PARP14	2.35e-20	1.08e-15	(2019) What Changed on the Folliculogenesis in the Process of Mouse Ovarian Aging?
PMID	PMID:22531325	13	81	9606	OAS3,BST2,SAMHD1,MX2,OAS2,STAT1,GBP1,ISG15,TRIM5,RSAD2,MX1,IFITM1,OAS1	OAS3,BST2,SAMHD1,MX2,OAS2,STAT1,GBP1,ISG15,TRIM5,RSAD2,MX1,IFITM1,OAS1	2.66e-20	1.19e-15	(2012) Interferon-inducible effector mechanisms in cell-autonomous immunity.
PMID	PMID:30496325	11	34	9606	MX2,OAS2,IFIT1,IFIT2,HLA-E,ISG15,DDX58,MX1,IFITM1,HLA-B,HLA-G	MX2,OAS2,IFIT1,IFIT2,HLA-E,ISG15,DDX58,MX1,IFITM1,HLA-B,HLA-G	3.11e-20	1.38e-15	(2018) Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity.
PMID	PMID:34785679	12	55	9606	BST2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1	BST2,OAS2,PARP9,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1	3.17e-20	1.39e-15	(2021) SARS-CoV-2 infection and replication in human gastric organoids.
PMID	PMID:26159724	13	83	9606	OAS3,MX2,OAS2,STAT1,GBP1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,IFI35	OAS3,MX2,OAS2,STAT1,GBP1,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,IFITM1,IFI35	3.55e-20	1.54e-15	(2015) Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands.
PMID	PMID:18648529	13	83	9606	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	3.55e-20	1.54e-15	(2008) Type I interferon: potential therapeutic target for psoriasis?
PMID	PMID:35197461	14	118	9606	MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFI30,IFITM1,IFI35	MX2,OAS2,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,IFI30,IFITM1,IFI35	3.86e-20	1.64e-15	(2022) Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection.
PMID	PMID:23455712	11	35	9606	BST2,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	BST2,STAT1,IFI44,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1	4.07e-20	1.71e-15	(2013) Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses.
PMID	PMID:27533247	12	57	9606	OAS2,SP100,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,SAMD9,MX1,HELZ2	OAS2,SP100,PARP9,STAT1,GBP1,IFI44,IFI44L,IFIT1,IFIT2,SAMD9,MX1,HELZ2	4.65e-20	1.93e-15	(2016) Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
PMID	PMID:35235083	10	20	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,MX2,OAS2,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	5.12e-20	2.1e-15	(2022) Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
PMID	PMID:34960172	10	20	9606	STAT1,IFI44,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	STAT1,IFI44,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	5.12e-20	2.1e-15	(2021) A Bioinformatics Approach to Identifying Potential Biomarkers for Cryptosporidium parvum: A Coccidian Parasite Associated with Fetal Diarrhea.
PMID	PMID:30936263	11	36	9606	SAMHD1,MX2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	SAMHD1,MX2,STAT1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	5.31e-20	2.14e-15	(2019) Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS.
PMID	PMID:25809693	11	36	9606	BST2,SAMHD1,MX2,OAS2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM1,HLA-B	BST2,SAMHD1,MX2,OAS2,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM1,HLA-B	5.31e-20	2.14e-15	(2015) Antiviral gene expression in psoriasis.
PMID	PMID:28804651	12	59	9606	OAS3,OAS2,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1,HLA-B	OAS3,OAS2,STAT1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1,HLA-B	6.73e-20	2.65e-15	(2017) Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.
RCTM	HSA-913531	23	196	9606	OAS3,BST2,SAMHD1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	2.55e-33	5.55e-30	Interferon Signaling
RCTM	HSA-909733	18	69	9606	OAS3,BST2,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT2,HLA-E,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,MX2,OAS2,STAT1,IFIT1,IFIT2,HLA-E,ISG15,RSAD2,MX1,IFITM3,IFITM1,OAS1,IFI35,HLA-B,HLA-G	1.73e-31	1.88e-28	Interferon alpha/beta signaling
RCTM	HSA-1280215	25	681	9606	OAS3,BST2,SAMHD1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	OAS3,BST2,SAMHD1,CSF1,MX2,OAS2,SP100,STAT1,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G	1.81e-24	1.31e-21	Cytokine Signaling in Immune system
RCTM	HSA-168256	29	1956	9606	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,C1R	OAS3,BST2,SAMHD1,DTX3L,TREX1,CSF1,MX2,OAS2,SP100,STAT1,CTSS,GBP1,IFIT1,IFIT2,HLA-E,ISG15,DDX58,TRIM5,RSAD2,LGALS9,MX1,IFITM3,IFI30,IFITM1,OAS1,IFI35,HLA-B,HLA-G,C1R	3.68e-18	2e-15	Immune System
RCTM	HSA-877300	11	88	9606	OAS3,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,IFI30,OAS1,HLA-B,HLA-G	OAS3,OAS2,SP100,STAT1,GBP1,HLA-E,TRIM5,IFI30,OAS1,HLA-B,HLA-G	3.53e-16	1.53e-13	Interferon gamma signaling
RCTM	HSA-1169410	9	81	9606	OAS3,MX2,OAS2,STAT1,IFIT1,ISG15,DDX58,MX1,OAS1	OAS3,MX2,OAS2,STAT1,IFIT1,ISG15,DDX58,MX1,OAS1	5.74e-13	2.08e-10	Antiviral mechanism by IFN-stimulated genes
RCTM	HSA-8983711	4	9	9606	OAS3,OAS2,DDX58,OAS1	OAS3,OAS2,DDX58,OAS1	1.86e-08	5.78e-06	OAS antiviral response
RCTM	HSA-1169408	6	73	9606	MX2,STAT1,IFIT1,ISG15,DDX58,MX1	MX2,STAT1,IFIT1,ISG15,DDX58,MX1	2.9e-08	7.88e-06	ISG15 antiviral mechanism
RCTM	HSA-1236977	4	11	9606	CTSS,HLA-E,HLA-B,HLA-G	CTSS,HLA-E,HLA-B,HLA-G	3.55e-08	8.56e-06	Endosomal/Vacuolar pathway
RCTM	HSA-983170	3	25	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	3.8e-05	0.0082	Antigen Presentation: Folding, assembly and peptide loading of class I MHC
RCTM	HSA-198933	4	129	9606	HLA-E,IFITM1,HLA-B,HLA-G	HLA-E,IFITM1,HLA-B,HLA-G	0.00026	0.0479	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
WikiPathways	WP4197	6	23	9606	STAT1,IFIT1,MX1,IFITM1,OAS1,IFI35	STAT1,IFIT1,MX1,IFITM1,OAS1,IFI35	5.41e-11	3.67e-08	Immune response to tuberculosis
WikiPathways	WP619	6	37	9606	STAT1,GBP1,IFIT2,ISG15,OAS1,HLA-B	STAT1,GBP1,IFIT2,ISG15,OAS1,HLA-B	6.78e-10	2.3e-07	Type II interferon signaling (IFNG)
WikiPathways	WP4868	5	31	9606	OAS3,OAS2,STAT1,DDX58,OAS1	OAS3,OAS2,STAT1,DDX58,OAS1	2.03e-08	4.58e-06	Type I interferon induction and signaling during SARS-CoV-2 infection
WikiPathways	WP4880	5	33	9606	OAS3,OAS2,STAT1,DDX58,OAS1	OAS3,OAS2,STAT1,DDX58,OAS1	2.69e-08	4.58e-06	Host-pathogen interaction of human coronaviruses - interferon induction
WikiPathways	WP4705	4	16	9606	SAMHD1,TREX1,DDX58,OAS1	SAMHD1,TREX1,DDX58,OAS1	1.25e-07	1.69e-05	Pathways of nucleic acid metabolism and innate immune sensing
WikiPathways	WP4217	6	129	9606	BST2,STAT1,HLA-E,DDX58,HLA-B,HLA-G	BST2,STAT1,HLA-E,DDX58,HLA-B,HLA-G	7.11e-07	7.44e-05	Ebola virus pathway in host
WikiPathways	WP5039	5	66	9606	STAT1,IFIT2,DDX58,MX1,IFITM1	STAT1,IFIT2,DDX58,MX1,IFITM1	6.58e-07	7.44e-05	SARS-CoV-2 innate immunity evasion and cell-specific immune response
WikiPathways	WP4341	5	71	9606	OAS2,STAT1,IFI44L,ISG15,RSAD2	OAS2,STAT1,IFI44L,ISG15,RSAD2	9.26e-07	7.85e-05	Non-genomic actions of 1,25 dihydroxyvitamin D3
WikiPathways	WP2328	4	89	9606	STAT1,HLA-E,HLA-B,HLA-G	STAT1,HLA-E,HLA-B,HLA-G	6.64e-05	0.005	Allograft Rejection
WikiPathways	WP4877	3	35	9606	BST2,IFITM3,IFITM1	BST2,IFITM3,IFITM1	9.62e-05	0.0065	Host-pathogen interaction of human coronaviruses - MAPK signaling
WikiPathways	WP183	3	60	9606	HLA-E,HLA-B,HLA-G	HLA-E,HLA-B,HLA-G	0.00043	0.0268	Proteasome degradation
WikiPathways	WP4655	3	73	9606	TREX1,ISG15,DDX58	TREX1,ISG15,DDX58	0.00075	0.0425	Cytosolic DNA-sensing pathway
HPO	HP:0030355	4	15	9606	SP110,SAMHD1,TREX1,STAT1	SP110,SAMHD1,TREX1,STAT1	1e-07	0.00099	Abnormal serum interferon-gamma level
HPO	HP:0009145	4	55	9606	SAMHD1,TREX1,STAT1,PRKAR1A	SAMHD1,TREX1,STAT1,PRKAR1A	1.1e-05	0.0217	Abnormal cerebral artery morphology
HPO	HP:0003207	3	23	9606	SAMHD1,TREX1,STAT1	SAMHD1,TREX1,STAT1	3.02e-05	0.05	Arterial calcification
NetworkNeighborAL	CL:19379	21	83	9606	OAS3,SP110,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,SAMHD1,DTX3L,TREX1,MX2,OAS2,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1,IFI35,PARP14	1.19e-36	5.41e-33	Mixed, incl. interferon alpha/beta signaling, and negative regulation of type i interferon production
NetworkNeighborAL	CL:19389	18	42	9606	OAS3,SP110,DTX3L,MX2,OAS2,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,DTX3L,MX2,OAS2,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,OAS1,IFI35,PARP14	8.63e-35	1.96e-31	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19385	19	61	9606	OAS3,SP110,DTX3L,MX2,OAS2,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1,IFI35,PARP14	OAS3,SP110,DTX3L,MX2,OAS2,PARP9,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM3,OAS1,IFI35,PARP14	1.51e-34	2.29e-31	Interferon alpha/beta signaling, and Negative regulators of DDX58/IFIH1 signaling
NetworkNeighborAL	CL:19391	14	36	9606	OAS3,MX2,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,GBP1,IFI44,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,IFITM3,OAS1,IFI35	1.5e-26	1.13e-23	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19394	10	21	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,RSAD2,MX1,IFITM3,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT2,RSAD2,MX1,IFITM3,OAS1,IFI35	7.54e-20	4.9e-17	Interferon alpha/beta signaling
NetworkNeighborAL	CL:19397	9	16	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,RSAD2,MX1,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT2,RSAD2,MX1,OAS1,IFI35	1.86e-18	1.05e-15	Microphthalmia with limb anomalies, and Interferon alpha/beta signaling
NetworkNeighborAL	CL:19399	8	11	9606	OAS3,MX2,OAS2,IFIT1,IFIT2,RSAD2,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT2,RSAD2,OAS1,IFI35	3.57e-17	1.8e-14	Mixed, incl. 2-5-oligoadenylate synthetase activity, and nephropathia epidemica
NetworkNeighborAL	CL:19402	4	5	9606	OAS2,IFIT1,IFIT2,RSAD2	OAS2,IFIT1,IFIT2,RSAD2	3.31e-09	1.5e-06	Mixed, incl. 4fe-4s single cluster domain, and interferon-induced protein with tetratricopeptide repeats 3
NetworkNeighborAL	CL:19437	4	13	9606	GBP1,IFI44,IFI44L,ISG15	GBP1,IFI44,IFI44L,ISG15	6.16e-08	2.55e-05	Mixed, incl. isg15-protein conjugation, and interferon-induced protein 44 family
NetworkNeighborAL	CL:19463	3	5	9606	DTX3L,PARP9,PARP14	DTX3L,PARP9,PARP14	6.71e-07	0.00025	Appr-1-p processing enzyme, and DTX3L, RING-HC finger
NetworkNeighborAL	CL:19438	3	7	9606	GBP1,IFI44,IFI44L	GBP1,IFI44,IFI44L	1.43e-06	0.0005	Mixed, incl. interferon-induced protein 44 family, and receptor-transporting protein 4
NetworkNeighborAL	CL:19526	2	6	9606	SAMHD1,TREX1	SAMHD1,TREX1	0.00015	0.0485	Aicardi-Goutieres syndrome
